Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Vaccinations

Vaccinations

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Tau T205 phosphorylation modulates engram cell recruitment and remote memory in mice.

Nature communications·2026

Same author

Development of a targeted BioPROTAC degrader selective for misfolded SOD1.

Nature communications·2025

Same author

The emerging roles of long non-coding RNAs in the nervous system.

Nature reviews. Neuroscience·2025

Same author

Long read sequencing reveals transgene concatemerization and vector sequences integration following AAV-driven electroporation of CRISPR RNP complexes in mouse zygotes.

Frontiers in genome editing·2025

Same author

Developmental differentiation of mouse inner ear neuron subpopulations resolved with a peripherin-promoter reporter within the Grm8 locus.

Scientific reports·2025

Same author

Engineered Cyclotide Blocks Neuronal Excitotoxicity.

Journal of medicinal chemistry·2024

Search research articles

Related Experiment Video

Updated: Sep 7, 2025

Author Spotlight: Development and Evaluation of a Cationic Nanoemulsion-Encapsulated Retinoic Acid System for Mucosal Vaccination

Author Spotlight: Development and Evaluation of a Cationic Nanoemulsion-Encapsulated Retinoic Acid System for Mucosal Vaccination

Published on: February 23, 2024

Recent progress in synthetic self-adjuvanting vaccine development.

Daryl Ariawan¹, Janet van Eersel¹, Adam D Martin¹

¹Dementia Research Centre, Department of Biomedical Science, Faculty of Medicine and Health Sciences, Macquarie University, Sydney, NSW 2109, Australia. lars.ittner@mq.edu.au.

Biomaterials Science

|June 16, 2022

Summary

Vaccines using peptides or small molecules need adjuvants for effectiveness. This review covers self-adjuvanting molecules like peptides, lipids, and polymers that enhance immune responses for better vaccination strategies.

More Related Videos

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches

Published on: May 6, 2015

Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation

Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation

Published on: August 21, 2019

Related Experiment Videos

Last Updated: Sep 7, 2025

Author Spotlight: Development and Evaluation of a Cationic Nanoemulsion-Encapsulated Retinoic Acid System for Mucosal Vaccination

Author Spotlight: Development and Evaluation of a Cationic Nanoemulsion-Encapsulated Retinoic Acid System for Mucosal Vaccination

Published on: February 23, 2024

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches

Published on: May 6, 2015

Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation

Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation

Published on: August 21, 2019

Area of Science:

Immunology
Vaccine Development
Bioconjugation Chemistry

Background:

Vaccination is crucial for infectious disease prevention, as seen with COVID-19.
Peptide or small molecule antigens offer alternative vaccine strategies but often lack immunogenicity.
Adjuvants are necessary to enhance the immune response to these novel antigens.

Purpose of the Study:

To review different moieties that can be conjugated to peptide antigens to improve immunogenicity.
To summarize various classes of self-adjuvanting molecules for vaccine development.
To highlight advancements in conjugated vaccine systems.

Main Methods:

Literature review of scientific publications on conjugated vaccine systems.
Analysis of different self-adjuvanting moieties and their mechanisms.
Categorization of moieties based on their chemical nature (peptides, lipids, polymers).

Main Results:

Conjugating specific moieties to peptide antigens significantly enhances immune responses.
Self-assembly peptides, lipids, glycolipids, and polymers are effective self-adjuvanting components.
These conjugated systems overcome the low immunogenicity of peptide or small molecule antigens.

Conclusions:

Conjugated systems represent a promising approach to developing effective peptide or small molecule-based vaccines.
Self-adjuvanting moieties are key to boosting immunogenicity and facilitating specific immune responses.
Further research into these advanced vaccine platforms holds potential for future disease prevention.